Medical research

Trial demonstrates acute lymphoblastic leukemia treatment advance

Late-breaking research reveals a major treatment advance for adults with newly diagnosed B lineage acute lymphoblastic leukemia (ALL). The randomized phase 3 study E1910 evaluated blinatumomab immunotherapy in patients with ...

Diseases, Conditions, Syndromes

Study reveals recommended anticoagulant therapy for COVID patients

The AustralaSian COVID-19 Trial (ASCOT) has pinpointed the most efficient level of blood thinning treatment needed for patients hospitalized with COVID-19, in a study published in the New England Journal of Medicine Evidence ...

page 13 from 40